This document provides a financial summary and analysis of GlaxoSmithKline (GSK) as of May 11, 2015. It includes data on stock performance, financial metrics, income statements, cash flow, and balance sheets. The document also contains Deutsche Bank estimates and market analysis for GSK.
documents/vol00010-efta01457558-pdf.pdf
{"title":"GlaxoSmithKline Financial Summary","document_date":"2015-05-11","document_type":"tabular","key_locations":["United Kingdom","Europe"],"key_organizations":["GlaxoSmithKline","Deutsche Bank"],"reference_numbers":["EFTA01457558","DB-SDNY-0117152","SDNY_GM_00263336"]}